002100.SZ
Tecon Biology Co., Ltd.
SZSE · Consumer Defensive · C 制造业 · CN
CNY 7.70
−2.41%Oct 25, 2026, 07:48 UTC
Tian Kang Bio reported revenue of CNY 12.817 billion and a net loss attributable to shareholders of CNY 596 million for the first three quarters of 2026.
Source:Oct 25, 2026, 07:48 UTC
Tian Kang Bio reported third-quarter 2026 revenue of CNY 4.492 billion, down 5.71% year over year, and a net loss attributable to shareholders of CNY 155 million.
Source:Oct 8, 2026, 03:41 UTC
Tian Kang Bio and Haid Group jointly established Alar Tian Kang Plant Protein Co., Ltd., with registered capital of 347 million yuan.
Source:Sep 9, 2026, 08:17 UTC
Tiankang Biopharmaceutical announced its August 2026 hog sales of 411,100 heads, up 1.41% year-on-year, with sales revenue of 417 million yuan, down 25.67% year-on-year.
Aug 28, 2026, 11:35 UTC
Tiankang Biopharmaceutical announced the termination of a non-public offering fundraising project for a pig breeding and fattening base, with remaining funds to be permanently used as working capital.
Source:Aug 26, 2026, 11:06 UTC
Tiankang Biological reported a net loss of 441 million yuan for the first half of 2026, turning from a profit of 338 million yuan in the same period of 2025.
Source:Aug 7, 2026, 10:38 UTC
Tiankang Biotech announced July 2026 hog sales of 396,100 heads, up 27.45% year-on-year, with sales revenue of 393 million yuan, down 12.47% year-on-year.
Source: